Celladon Corporation (CLDN) was a big mover last session, as its shares rose nearly 6% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This reverses the downtrend for the healthcare company since March 24, as the stock is down nearly 25%.
In the last 30 days, the company did not witness any estimate revision and the Zacks Consensus Estimate also remained unchanged. Yesterday’s price action is encouraging though, so make sure to keep a close watch on this firm in the near future.
Celladon currently carries a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.
Other better-ranked stocks in the medical sector include ANI Pharmaceuticals, Inc. (ANIP), Alkermes plc (ALKS) and Alexion Pharmaceuticals, Inc. (ALXN). All three sport a Zacks Rank #1 (Strong Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
To read this article on Zacks.com click here.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
Be the first to comment